Skip to content

CorMedix CRMD Income Tax Reconciliation Foreign Income Tax Rate Differential

Income Tax Reconciliation Foreign Income Tax Rate Differential at other companies

Baxter International logo
Baxter InternationalBAX
$34.25M-27.9%
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential.

The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's income tax reconciliation foreign income tax rate differential.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's income tax reconciliation foreign income tax rate differential?
CorMedix (CRMD) reported income tax reconciliation foreign income tax rate differential of $14.25K in Q4 2024.
What does income tax reconciliation foreign income tax rate differential mean?
Reflects the specific tax effects arising from foreign operations, including adjustments for foreign tax rates that differ from the domestic statutory rate. This metric helps isolate the tax impact of international expansion and global revenue generation. Investors use it to evaluate the tax-related risks and benefits of operating in multiple countries.